Literature DB >> 8903466

Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma.

H Rabinowich1, Y Suminami, T E Reichert, P Crowley-Nowick, M Bell, R Edwards, T L Whiteside.   

Abstract

We have reported that tumor-associated T or natural killer (NK) lymphocytes purified from ascites of women with ovarian carcinoma show defective expression and function of signaling proteins, including reduced expression of TcR-zeta chains and p56(lck). In this study, the cytokine profiles of both tumor cells and tumor-associated lymphocytes (TAL) recovered from the tumor milieu were examined. Expression of cytokine genes was studied by semi-quantitative RT-PCR and Southern hybridization, and the presence of intracellular cytokine proteins was confirmed by immunostaining. Levels of mRNA encoding the cytokine genes typically transcribed in activated T lymphocytes, including IFN-gamma, IL-2 and IL-4, were markedly reduced, as was expression of the corresponding proteins, in TAL-T or TAL-NK cells relative to normal PBL-T or PBL-NK cells, respectively. Levels of TGF-beta and IL-6 were unaltered, while those of IL-10 were up-regulated. Although both tumor cells and TALs contributed to the enhanced level of IL-10 expression, a higher proportion of TAL-T lymphocytes than normal PBL-T cells expressed IL-10 protein. The altered profile of cytokine genes and proteins in TALs, TAL-T or TAL-NK cells was associated with impaired expression and/or function of signaling molecules, zeta chain and p56(lck). Our data suggest that abnormalities in signal transduction commonly seen in lymphocytes obtained from the tumor micro-environment are related to the concomitantly observed altered patterns of expression of cytokine transcripts and proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903466     DOI: 10.1002/(SICI)1097-0215(19961104)68:3<276::AID-IJC2>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  The onset and extent of genomic instability in sporadic colorectal tumor progression.

Authors:  D L Stoler; N Chen; M Basik; M S Kahlenberg; M A Rodriguez-Bigas; N J Petrelli; G R Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Heat shock protein 10 (Hsp10) in immune-related diseases: one coin, two sides.

Authors:  Haibo Jia; Amadou I Halilou; Liang Hu; Wenqian Cai; Jing Liu; Bo Huang
Journal:  Int J Biochem Mol Biol       Date:  2010-12-25

3.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16

4.  Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Authors:  Jennifer A Belisle; Sachi Horibata; Gubbels A A Jennifer; Sarah Petrie; Arvinder Kapur; Sabine André; Hans-Joachim Gabius; Claudine Rancourt; Joseph Connor; James C Paulson; Manish S Patankar
Journal:  Mol Cancer       Date:  2010-05-24       Impact factor: 27.401

5.  Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.

Authors:  Susan K Lutgendorf; Donald M Lamkin; Koen DeGeest; Barrie Anderson; Minh Dao; Stephanie McGinn; Bridget Zimmerman; Heena Maiseri; Anil K Sood; David M Lubaroff
Journal:  Brain Behav Immun       Date:  2008-02-13       Impact factor: 7.217

6.  Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.

Authors:  H Rabinowich; T E Reichert; Y Kashii; B R Gastman; M C Bell; T L Whiteside
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  T cell avidity and tumor recognition: implications and therapeutic strategies.

Authors:  Mark D McKee; Jeffrey J Roszkowski; Michael I Nishimura
Journal:  J Transl Med       Date:  2005-09-20       Impact factor: 5.531

8.  Immunologic aspect of ovarian cancer and p53 as tumor antigen.

Authors:  H W Nijman; A Lambeck; S H van der Burg; A G J van der Zee; T Daemen
Journal:  J Transl Med       Date:  2005-09-15       Impact factor: 5.531

9.  Ovarian cancer, the coagulation pathway, and inflammation.

Authors:  Xipeng Wang; Ena Wang; John J Kavanagh; Ralph S Freedman
Journal:  J Transl Med       Date:  2005-06-21       Impact factor: 5.531

10.  Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC).

Authors:  Ralph S Freedman; Michael Deavers; Jinsong Liu; Ena Wang
Journal:  J Transl Med       Date:  2004-06-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.